Where travel agents earn, learn and save!

November 21 2024 / 10:30 PM
No Data Found

No data found

Longwoods International
With vaccines arriving, U.S. trip planning surges

February 12 - According to the latest Longwoods International tracking study of American travelers, 81% plan to travel in the next six months, an increase of 16 percentage points since mid-January and the highest level since the beginning of the pandemic last March. Coupled with a surge in travel plans for the upcoming six months, the percentage of travelers who say that the coronavirus is greatly impacting their decision to travel during this time period has dropped to 40%, the lowest level since March 2020.

 

The arrival of multiple coronavirus vaccines has reignited travel planning in the U.S.,” said Amir Eylon, President and CEO of Longwoods International. “The travel industry recovery appears poised to track in synch with the success of the mass vaccination program now underway across America.

 

Vaccines are top of mind for American travelers with two thirds saying the vaccine will impact their travel plans. More than a third of travelers do not plan to travel until they are vaccinated, and a fifth of travelers do not plan to travel until a majority of Americans have received the vaccine.

 

The survey, supported by Miles Partnership, was fielded February 3, 2021 using a national sample randomly drawn from a consumer panel of 1,000 adults, ages 18 and over. Quotas were used to match Census targets for age, gender, and region to make the survey representative of the U. S. population.

 

Click here to see U.S. Travel Sentiment Survey.

 

 


More Travel News:

Airbus seeks to turn Paris into a Hydrogen Hub
Caribbean Travel Marketplace goes Virtual in 2021!
JetBlue marks airline’s 21st Anniversary with first flights in Miami and Key West, Fla. as part of latest targeted growth plan
Restrictions to mobility have contributed to the UK suffering greater GDP losses than its European neighbours, says WTTC

Jul 21, 2021

Latest Post

Subscribe to our newsletter